O-017SUNRISE-DI study: decision impact of the 12-gene recurrence score (12-RS) assay on adjuvant chemotherapy recommendation for stage II and IIIA/B colon cancer. (2nd July 2019) - Watanabe, J; Sato, T; Kagawa, Y; Oki, E; Kuboki, Y; Ikeda, M; Ueno, H; Kato, T; Kusumoto, T; Masuishi, T; Yamaguchi, K; Kanazawa, A; et al.